Innate Pharma (IPHA) Stock News
$IPHA · NASDAQ · HEALTHCARE · 1 stories in 30 daysBORSA has published 1 story on Innate Pharma (IPHA) in the past 30 days. BORSA’s news read on IPHA is balanced at 50/100, based on 1 company event over the past 7 days. IPHA last closed at $1.43 on Oct 16, down 11.73% over five sessions and down 25.13% over the past month. Innate Pharma last reported quarterly results on May 13, 2026, for the quarter ended Mar 31, 2026.
The wire on $IPHA
newest first · updated · direct subject stories onlyInnate Pharma will hold a conference call on November 5, 2026 at 8 a.m. ET to discuss its third-quarter business and financial update. CEO Jonathan Dickinson and other executives will participate.
neutral 50 · impact 10The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
Innate Pharma (IPHA) stock: common questions
What is the latest Innate Pharma stock news?
The highest-impact IPHA story BORSA published in the past 30 days:
· Innate Pharma schedules Q3 2026 conference call for November 5